Keros Therapeutics, Inc. Capital Expenditures
Keros Therapeutics, Inc. (KROS) reported Capital Expenditures of $228.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $155.00K, a 78.47% decline year-over-year.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $73.00K, a 87.08% decline year-over-year.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $134.00K, a 53.63% decline year-over-year.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $132.00K, a 65.80% decline year-over-year.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.55M, a 19.68% decline from fiscal 2024.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.93M, a 21.63% decline from fiscal 2023.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $2.46M, a 98.55% increase from fiscal 2022.
- Keros Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.24M, a 21.19% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $228.00K 10-Q · filed 2026-08-03 | $362.00K derived: sum of 3 quarters · filed 2026-08-03 | $494.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $73.00K 10-Q · filed 2026-05-14 | $207.00K derived: sum of 2 quarters · filed 2026-05-14 | $339.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.06M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $266.00K derived: sum of 2 quarters · filed 2026-03-04 | $986.00K derived: sum of 3 quarters · filed 2026-08-03 | $1.55M 10-K · filed 2026-03-04 |
| 2025-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $852.00K derived: sum of 2 quarters · filed 2026-08-03 | $1.42M 10-Q · filed 2025-11-05 | $1.71M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $720.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.28M 10-Q · filed 2026-08-03 | $1.57M derived: sum of 3 quarters · filed 2026-08-03 | $1.96M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $565.00K 10-Q · filed 2026-05-14 | $854.00K derived: sum of 2 quarters · filed 2026-05-14 | $1.24M derived: sum of 3 quarters · filed 2026-05-14 | $1.55M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $289.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $675.00K derived: sum of 2 quarters · filed 2026-03-04 | $985.00K derived: sum of 3 quarters · filed 2026-03-04 | $1.93M 10-K · filed 2026-03-04 |
| 2024-09-30 | $386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $696.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.64M 10-Q · filed 2025-11-05 | $2.18M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $310.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $1.26M 10-Q · filed 2025-08-06 | $1.80M derived: sum of 3 quarters · filed 2025-08-06 | $2.35M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $946.00K 10-Q · filed 2025-05-06 | $1.49M derived: sum of 2 quarters · filed 2025-05-06 | $2.04M derived: sum of 3 quarters · filed 2025-05-06 | $2.35M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.09M derived: sum of 2 quarters · filed 2025-02-26 | $1.40M derived: sum of 3 quarters · filed 2025-02-26 | $2.46M 10-K · filed 2025-02-26 |
| 2023-09-30 | $550.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $861.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.92M 10-Q · filed 2024-11-06 | $2.27M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $311.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.37M 10-Q · filed 2024-08-07 | $1.72M derived: sum of 3 quarters · filed 2025-02-26 | $1.90M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.06M 10-Q · filed 2024-05-08 | $1.41M derived: sum of 2 quarters · filed 2025-02-26 | $1.59M derived: sum of 3 quarters · filed 2025-02-26 | $2.16M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $527.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.09M derived: sum of 3 quarters · filed 2025-02-26 | $1.24M 10-K · filed 2025-02-26 |
| 2022-09-30 | $176.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $743.00K derived: sum of 2 quarters · filed 2023-11-06 | $890.00K 10-Q · filed 2023-11-06 | $1.05M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $714.00K 10-Q · filed 2023-08-07 | $873.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $147.00K 10-Q · filed 2023-05-04 | $306.00K derived: sum of 2 quarters · filed 2024-02-28 | $451.00K derived: sum of 3 quarters · filed 2024-02-28 | $961.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $304.00K derived: sum of 2 quarters · filed 2024-02-28 | $814.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.02M 10-K · filed 2024-02-28 |
| 2021-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $655.00K derived: sum of 2 quarters · filed 2022-11-03 | $865.00K 10-Q · filed 2022-11-03 | $925.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $720.00K 10-Q · filed 2022-08-04 | $780.00K derived: sum of 3 quarters · filed 2022-08-04 | $810.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $210.00K 10-Q · filed 2022-05-05 | $270.00K derived: sum of 2 quarters · filed 2022-05-05 | $300.00K derived: sum of 3 quarters · filed 2022-05-05 | $328.00K derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $90.00K derived: sum of 2 quarters · filed 2022-03-09 | $118.00K derived: sum of 3 quarters · filed 2022-03-09 | $294.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $58.00K derived: sum of 2 quarters · filed 2021-11-04 | $234.00K 10-Q · filed 2021-11-04 | $252.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $204.00K 10-Q · filed 2021-08-05 | $222.00K derived: sum of 3 quarters · filed 2021-08-05 | $304.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $176.00K 10-Q · filed 2021-05-06 | $194.00K derived: sum of 2 quarters · filed 2021-05-06 | $276.00K derived: sum of 3 quarters · filed 2021-05-06 | $447.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $100.00K derived: sum of 2 quarters · filed 2021-03-25 | $271.00K derived: sum of 3 quarters · filed 2021-03-25 | $271.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $253.00K derived: sum of 2 quarters · filed 2020-11-10 | $253.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $171.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |